International classification criteria created for IgG4-related disease
Sign Up to like & getrecommendations! Published in 2020 at "Nature Reviews Rheumatology"
DOI: 10.1038/s41584-019-0367-7
Abstract: Iscalimab, an anti-CD40 monoclonal antibody, showed preliminary efficacy for the treatment of primary Sjögren syndrome (pSS) in a phase II placebo-controlled trial (n = 44). Of the two administration routes tested (intravenous and subcutaneous), only… read more here.
Keywords: criteria created; classification criteria; disease; igg4 related ... See more keywords